Neumiller, J.J. (2014) Empagliflozin: A New Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes. Drugs Context, 3, Article ID: 212262.
https://doi.org/10.7573/dic.212262

has been cited by the following article: